Voima Ventures

Christmas greetings from Stockholm 🎄👋 We gathered a couple of our founders for an excellent Christmas lunch at Villa Godthem, located at the beautiful Djurgården in Stockholm. Currently, we have 8 Swedish portfolio companies across different industries and stages 🧬 🌿 💻 It's always inspiring to see how much the portfolio companies can benefit from one another, regardless of the sector or stage they're in. Thanks for coming and for the great conversations ✨ Cellfion Liam Hardey hormona Karolina Löfqvist ArgusEye Nathalie Elsässer Farang Emil Romanus CubaseBio Paulius Mielinis Inka Mero Stina Wallmark Jenny Engerfelt

Impressive milestone by the Desentum team starting this Phase 2 Clinical study, to build further data showing the impact the DM101PX can have treating Birch pollen allergies. At Voima Ventures we are proud to be part of the journey supporting our portfolio company and building value with true global health impact.

Last week, we had an eventful week at Voima Ventures filled with milestones across our portfolio. Here are a few highlights in case you missed it 👇 👓 AAC Technologies acquired Dispelix: Dispelix is originally a spinoff from VTT and has been at the forefront of diffractive optics and waveguide technology. Dispelix is moving to truly global commercialization across consumer electronics, but also automotive and defence. The partnership with AAC will scale it faster than ever. 🥼 Leading the €7.5M round in Gosta Labs - an AI operating system that captures each patient encounter as high-quality structured data, which supports decision-making in real time, and frees clinicians from hours of manual documentation. Founded by serial entrepreneurs Lauri Sippola and Henri Viertolahti 🛰️ Kuva Space raises €8M in four hours with Springvest Oyj. A testament to both their traction and to the rising global demand for resilient space-based intelligence. Kuva Space continues to shape the future of Earth observation with both speed and execution. A week like this captures why we invest in science-based companies with an impact on people, planet, and industry. The Nordic deep-tech ecosystem is accelerating, and we are excited to help shape its trajectory 🚀

Today we’re proud to announce that we're leading the €7.5M seed round in Gosta Labs, a team shaping what the future of cancer care can look like when world class clinical expertise meets real, usable AI 🚀 Oncology is entering an era of immense complexity. Millions more patients, hundreds of cancer types, rapidly evolving treatment options and care teams stretched far beyond what current systems allow. If we want healthcare systems to keep up, the tools must change. Gosta Labs is building an AI operating system that captures each patient encounter as high quality structured data, supports decision making in real time, and frees clinicians from hours of manual documentation. The company is already working with leading hospitals across Finland, Switzerland, the Baltics and Australia 🌏 We invested because this is the type of company that can redefine a critical part of global healthcare: a founding team with a proven track record, deep medical understanding, and the technical ambition needed to build a trustworthy AI foundation for complex medicine. In the video below, the Lauri Sippola, the CEO and one of the co-founders, shares why this matters and how the technology is already reshaping oncology workflows. Jussi Sainiemi is also sharing why we chose to invest 💡 Participating co-investors in this round are COR Group Oy, the Aho family, and both existing and new investors, including Reaktor and a group of notable angel investors. Welcome Gosta Labs. The next chapter of intelligent, patient centered cancer care is being built now.

We're celebrating a milestone moment as Dispelix enters a new era together with AAC Technologies 🙌 As one of the earliest investors, we have had the privilege to support the company from its VTT origins to becoming a global leader in diffractive optics and waveguide innovation. With the rapid rise of AI, the world is ready for a new wave of AR adoption. Dispelix is uniquely positioned to deliver across consumer electronics, automotive and defence, and this partnership will accelerate global scale and impact. Congrats to the whole team and thanks to all co-investors, board members and of course the operative team for making this happen ✨

Slush 2025 - It's a wrap ✨ 🚀 Once again, Slush does what it does best - connecting people and bringing light to the impact that startups and scale-ups have on society and on our future. Some of our key highlights this year: ⭐ Future AI talent at Junction. We hosted workshops at Junction in Espoo, where over 1,500 developers participated in a 48-hour hackathon. It was inspiring to see so many students and hackers build solutions around generative AI, quantum, and robotics. Huge thanks to our friends at Junction and to Aino Bergius (CEO of Slush) and especially Joel Lahtinen (CEO of Junction) + team for championing inclusive, tech‑savvy leadership. ⭐ ELLIS Institute Finland launch with the Nordic and global AI leaders gathering to discuss how to connect science and societies for building the next AI companies. Great conversations Peter Sarlin Oliver Molander Ilkka Paananen ⭐ Ecosystem workshops & side events. Our team joined side events hosted by Nordea, OpenAI, Pale blue dot, OTB Ventures, Amadeus Capital Partners, Kvanted ALTOR, to name a few. We met with investors, LPs, and corporates to discuss topics from quantum chips to sustainable materials. Across the week, we met over 150 fellow VCs and hundreds of founders. ⭐ Hosted AI drinks for the DETECT network (Deep tech venture collective) with our co-members APEX Ventures and our friends at Wave Ventures. These informal gatherings help build trust and bring together the important networks across the continents. Join us next year, we promise karaoke well into the night.. ⭐ Y‑Science & life‑science innovation. Y‑Science, Slush’s life‑science side event, returned for its 8th edition with 1,500 attendees. The event encourages collaboration between researchers and industry, and we were delighted to see world‑class biotech and health‑tech teams from the University of Helsinki and VTT on stage. What’s next? Slush 2025 showed that deep‑tech is no longer a niche. Europe’s AI ecosystems are blooming, the defence sector is drawing top talent and capital, and our universities are spinning out world‑class companies. Dual‑use technology allows us to hedge against uncertainty and build the next wave of tech companies. We’re have selected our own Voima Ventures top 100 startups from Slush and are planning follow‑up meetings. Thank you to our friends at Y‑Science, Aalto University, VTT, Nordea, Junction, DETECT, and countless founders for making Slush such a vibrant gathering. We can assure you that visiting Helsinki in the cold and dark period will bring lots of light and hope 🙌 Team Voima Ventures

Slush season is just around the corner 👀 🙌 Hope to see you there? Slush is one of the Nordic region's most energizing gatherings for founders and investors. It’s a place where consumer meets climate, where software meets science, and where bold ideas from every corner of tech collide. And of course, deep tech is one of the beating hearts of it all 👩🔬 👨🔬 For us at Voima Ventures, Slush is the annual moment when the entire Nordic and Baltic ecosystem comes together. Our team will be in Helsinki throughout the week, connecting with builders across AI, biotech, materials, energy, quantum, and everything in between. If you’re working on something transformative, we’d love to hear your story ✨ Reach out to set up a meeting or just say hi when you spot us. See you in Helsinki! 🇫🇮 Niko Elers Inka Mero Jussi Sainiemi Jenny Engerfelt Pontus Stråhlman Linda H. Linda Noronen Stella Malka